Acro Biomedical cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 42 quarters of results from Sep 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||||||||||||||
| Net Income | -0.79M | -2.99M | -2.24M | -3.93M | -4.00M | -4.01M | -3.93M | -4.00M | -3.20M | -1.59M | 1.83M | -0.01M | -0.01M | -0.01M | -0.00M | -0.01M | -0.02M | -0.12M | 0.06M | -0.02M | ||||||||||||||||||||||
| Share-based CompensationStock Comp. | 2.92M | 3.93M | ||||||||||||||||||||||||||||||||||||||||
| Deferred Taxes | ||||||||||||||||||||||||||||||||||||||||||
| Asset Writedowns and ImpairmentWritedown | 0.48M | |||||||||||||||||||||||||||||||||||||||||
| Cash from OperationsCash from Ops. | 0.43M | -0.06M | -0.06M | 0.26M | -0.35M | -0.05M | -0.01M | -0.01M | 0.00M | 483.00 | -0.01M | -0.01M | -0.01M | -0.01M | -0.01M | -0.02M | -0.09M | -0.05M | -0.03M | |||||||||||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | -0.60M | -0.30M | 0.60M | -0.62M | 0.36M | -0.03M | -0.11M | -0.02M | ||||||||||||||||||||||||||||||||||
| Change in InventoryChange Inventory | -0.56M | 0.98M | 0.45M | -0.30M | 0.59M | -0.30M | ||||||||||||||||||||||||||||||||||||
| Change in Account PayablesChange Payables | 0.00M | 0.01M | ||||||||||||||||||||||||||||||||||||||||
| Change in Accured ExpensesChange Accured Exp. | -0.00M | 0.00M | -0.03M | 0.01M | 0.01M | 0.06M | 0.05M | -0.04M | 0.07M | 0.00M | -0.00M | 442.00 | 0.00M | -0.00M | -0.01M | -0.05M | 0.02M | -0.00M | ||||||||||||||||||||||||
| Change in TaxesChange Taxes | ||||||||||||||||||||||||||||||||||||||||||
| Other Working Capital ChangesOther WC Changes | ||||||||||||||||||||||||||||||||||||||||||
| Financing Activities | ||||||||||||||||||||||||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | -0.24M | 0.00M | 0.00M | 288.00 | 216.00 | 0.06M | 232.00 | 36.00 | 108.00 | 108.00 | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.02M | 0.09M | 0.06M | 0.03M | |||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||||||||
| Change in Cash | 0.19M | -0.06M | -0.06M | 0.26M | -0.35M | 0.00M | -0.01M | -0.01M | 0.00M | 591.00 | -0.00M | -225.00 | 775.00 | -225.00 | -225.00 | -225.00 | -225.00 | 0.00M | -225.00 | |||||||||||||||||||||||
| Free Cash FlowFCF | 0.43M | -0.06M | -0.06M | 0.26M | -0.35M | -0.05M | -0.01M | -0.01M | 0.00M | 483.00 | -0.01M | -0.01M | -0.01M | -0.01M | -0.01M | -0.02M | -0.09M | -0.05M | -0.03M | |||||||||||||||||||||||
| Net Cash FlowNCF | 0.19M | -0.06M | -0.06M | 0.26M | -0.35M | 0.00M | -0.01M | -0.01M | 0.00M | 591.00 | -0.00M | -225.00 | 775.00 | -225.00 | -225.00 | -225.00 | -225.00 | 0.00M | -225.00 |